When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA-approved drug for ulcerative colitis also effective for ...

   www.aol.com/fda-approved-drug-ulcerative-colitis...

   “Despite continued advances, people living with ulcerative colitis and Crohn’s disease are still seeking treatments that can address difficult-to-manage symptoms, such as bowel urgency, and ...

3. Targeted therapy may help treat moderate to severe ulcerative ...

   www.aol.com/targeted-therapy-may-help-treat...

   “There has been a great deal of progress in developing new, more effective and safe agents to treat inflammatory bowel diseases (Crohn’s disease and ulcerative colitis) over the last 20 years.

4. Biological therapy for inflammatory bowel disease - Wikipedia

   en.wikipedia.org/wiki/Biological_therapy_for...

   The previous treatment options had many shortcomings, and the introduction of biological therapy changed the way physicians treat Crohn's disease and ulcerative colitis. [ 5 ] [ 6 ] Even so, biologic therapy still has its faults such as high cost and risk of side effects.

5. Ulcerative colitis - Wikipedia

   en.wikipedia.org/wiki/Ulcerative_colitis

   As of early 2022, Roche halted clinical trials for the use of etrolizumab in the treatment of ulcerative colitis. [203] A type of leukocyte apheresis, known as granulocyte and monocyte adsorptive apheresis, still requires large-scale trials to determine whether or not it is effective. [204] Results from small trials have been tentatively ...

6. Inflammatory bowel disease - Wikipedia

   en.wikipedia.org/wiki/Inflammatory_bowel_disease

   Dietary patterns are associated with a risk for ulcerative colitis. In particular, subjects who were in the highest tertile of the healthy dietary pattern had a 79% lower risk of ulcerative colitis. [26] Gluten sensitivity is common in IBD and associated with having flareups. Gluten sensitivity was reported in 23.6% and 27.3% of Crohn's disease ...

7. Infliximab - Wikipedia

   en.wikipedia.org/wiki/Infliximab

   Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases.This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease. [23]